Another study demonstrated that patients with testicular cancer treated with chemotherapy are at greater risk of lower cognitive performance30, which could be related to anxiety and depression31. A Norwegian study on 1,408 testicular cancer survivors found that anxiety disorder was prevalent in this ...
02 Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy 白介素-6是一种肝细胞癌联合免疫治疗患者循环预后的生物标志物 Yuta Myojin et al. https://www.mdpi....
We further assessed disease specificity of the classifier in patients with colon-related benign diseases (n= 49) and patients with colorectal (n= 71), gastric (n= 61), liver (n= 25), pancreatic (n= 34) and thyroid (n= 46) cancer. Compared to the 86% call rate in colorectal cancer ...
Plasma prostaglandins in mucositis due to radiotherapy and chemotherapy for head and neck cancer. Patients with head and neck cancer were treated with synchronous radiotherapy and chemotherapy (vincristine, bleomycin and methotrexate). Before treatment,... NS Tanner,IF Stamford,A Bennett - 《Br J Ca...
Cervical cancer—Whether patients with recurrent disease metastatic to sites outside the pelvis should be treated with chemotherapy plus an angiogenic inhibitor. Uterine cancer—Whether patients with metastatic disease should receive ifosfamide plus paclitaxel. Genome analysis—Whether genomic analysis is criti...
We hypothesize and propose that alongside combination antiretroviral therapy (cART), some patients with HIV/AIDS associated malignancies should be treated with immunotherapy targeting PD-1/PD-L1 pathway rather than chemotherapy. The rationale and basis for the new approach is presented....
with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B... MC Stauder,YI Garces - Springer Berlin Heidelberg 被引量: 95发表: 2005年 Feasibility of curative radiotherapy with a concomitant boost techni...
Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients Kurzrock, Tumor mutational burden as an in- dependent predictor of response to immunotherapy in diverse cancers, Mol. Cancer Ther. 16 (11) (2017...
Cancer is a malignant tumor that seriously threatens human life and health. At present, the main treatment methods include surgical resection, chemotherapy, radiotherapy, and immunotherapy. However, the mechanism of tumor occurrence and development is co
megabase generally have a favorable prognosis11. Second, several retrospective studies indicate that 15–20% of CUP patients who receive site-specific chemotherapy have improved overall survival (OS) compared to patients treated with empiric chemotherapy6,12,13,14. The remaining 80–85% do not have...